JP
Insider buying
James Paul Rickey bought $500K of BRVE stock
James Paul Rickey, Chief Financial Officer of Braveheart Bio, Inc. (BRVE), bought 27,777 shares of BRVE stock worth $500K, per an SEC Form 4 filed Aug 7, 2026.
It was an open-market purchase.
The trade happened on Aug 5, 2026, 2 days before it was made public.
- Traded
- Aug 5, 2026
- Disclosed
- Aug 7, 2026
- Filing delay
- 2 days
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More BRVE insider and Congress trades
- BuyBRVE · Erez Chimovits$34.9MAug 11, 2026
- BuyBRVE · Orbimed Advisors LLC$34.9MAug 11, 2026
- BuyBRVE · AH Bio Fund IV, L.P.$19.8MAug 11, 2026
- BuyBRVE · Forbion Growth Opportunities Fund III Cooperatief U.A.$64.8MAug 7, 2026
- BuyBRVE · Travis Murdoch$1.5MAug 7, 2026
- BuyBRVE · David Charles Lubner$1000KAug 7, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.